RadNet, Inc.

RDNT

RadNet, Inc.

RDNT

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-18Shares Purchased (TTM):0Shares Sold (TTM):290,782

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:69,701,425Shares Outstanding:77,057,835Institutional Ownership Pct.:90.45%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Medical Laboratories

NTRA DGX LH GH CELC CAI

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Affiliated Entity	11	13	-1	-22	35	42	1	-5	34	25	3	22
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	455	767	805	833	717	740	749	742	527	343	338	357
Accounts Receivable Net Current	209	200	211	200	200	186	199	195	190	164	168	174
Prepaid Expense And Other Assets Current	65	52	50	48	64	52	38	39	45	48	48	49
Assets Current	741	1,032	1,078	1,094	1,016	1,019	1,016	1,005	796	579	579	603
Property Plant And Equipm…
Property Plant And Equipment Net	862	808	781	741	708	695	664	653	619	604	577	576
Operating Lease Right Of Use Asset	761	690	675	666	666	640	647	624	622	596	613	627
Other Assets
Goodwill	1,095	908	828	752	717	711	712	709	694	679	676	688
Other Intangible Assets Net	253	149	125	91	80	81	84	84	87	91	92	100
Deferred Finance Costs Noncurrent Net	2	2	2	2	2	2	2	3	1	2	2	2
Investments In Affiliates Subsidiaries Associates …	131	130	129	126	111	104	105	101	97	93	94	52
Deferred Income Tax Assets Net	-	-	5	-	-	-	-	-	-	-	-	-
Deposits Assets	40	40	43	43	36	35	45	51	53	46	54	57
Assets	3,885	3,759	3,665	3,515	3,336	3,287	3,275	3,229	2,970	2,690	2,688	2,705
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	455	422	419	407	368	351	339	354	325	343	302	333
Contract With Customer Liability Current	12	7	8	3	3	3	4	4	4	5	5	5
Operating Lease Liability Current	67	62	60	60	58	57	59	59	58	56	59	60
Notes Payable Current	27	25	25	25	25	25	23	24	20	18	16	16
Liabilities Current	636	587	575	546	505	480	470	474	428	437	407	434
Liabilities Noncurrent
Finance Lease Liability Noncurrent	4	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	777	707	691	679	678	656	658	632	630	605	614	629
Long Term Notes Payable	1,060	1,064	1,071	1,077	985	992	996	1,002	814	812	844	848
Deferred Income Tax Liabilities Net	34	22	0	21	28	22	21	17	14	16	17	10
Other Liabilities Noncurrent	22	23	15	12	3	4	10	10	5	7	10	23
Liabilities	2,533	2,403	2,351	2,336	2,200	2,153	2,156	2,137	1,892	1,877	1,892	1,944
Stockholders Equity
Stockholders Equity Note
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,212	1,180	1,147	1,026	1,017	988	979	974	969	723	715	704
Accumulated Other Comprehensive Income Loss Net Of…	-2	5	6	7	-4	-9	-2	-8	-14	-12	-18	-15
Retained Earnings Accumulated Deficit	-129	-95	-95	-100	-115	-77	-82	-85	-82	-80	-78	-95
Stockholders Equity	1,353	1,090	1,314	932	1,137	1,133	1,120	1,093	1,077	813	796	593
Minority Interest	272	266	255	247	238	231	224	212	204	183	177	168
Liabilities And Stockholders Equity	3,885	3,759	3,665	3,515	3,336	3,287	3,275	3,229	2,970	2,690	2,688	2,705
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	79	77	77	75	75	77	74	74	74	74	68	68
Shares Outstanding	79	74	77	75	75	74	74	74	74	68	68	68

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-2.79%	22.99%	-	-	-	-	-	-	-	-	-	-
2025	2.84%	-1.46%	-4.10%	15.18%	25.23%	22.56%	-2.80%	-12.24%	-13.30%	-25.35%	-23.38%	-27.68%
2024	6.14%	6.64%	12.18%	5.51%	10.35%	5.63%	-2.37%	-14.45%	-21.68%	-2.77%	-1.16%	11.33%
2023	-	-	-	3.36%	-10.54%	-19.33%	17.20%	17.98%	26.43%	26.89%	22.87%	51.74%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.17	1.76	1.87	2.00	2.01	2.12	2.16	2.12	1.86	1.32	1.42	1.39
Quick Ratio	1.06	1.67	1.79	1.92	1.88	2.02	2.08	2.04	1.75	1.22	1.30	1.27
Working Capital	105.14M	445.36M	502.86M	548.17M	510.46M	539.54M	546.12M	530.52M	367.94M	141.82M	171.60M	168.46M
Leverage & Debt
Debt to Equity	1.87	1.77	1.79	2.51	1.94	1.90	1.93	1.96	1.76	2.31	2.38	3.28
Interest Coverage TTM	0.88	0.89	0.84	0.91	0.86	1.31	1.33	1.52	1.59	1.53	1.52	1.00
Debt Ratio	0.65	0.64	0.64	0.66	0.66	0.66	0.66	0.66	0.64	0.70	0.70	0.72
Efficiency & Turnover
Asset Turnover TTM	0.59	0.58	0.57	0.57	0.59	0.61	0.59	0.58	0.62	0.63	0.64	0.62
Days Sales Outstanding TTM	34.83	34.54	37.96	37.81	38.05	34.86	37.76	39.38	40.28	37.26	39.30	40.71
Receivables Turnover TTM	10.48	10.57	9.62	9.65	9.59	10.47	9.67	9.27	9.06	9.80	9.29	8.97
Per Share Metrics
Diluted EPS TTM	-0.07	-0.25	-0.17	-0.19	-0.55	0.04	0.36	0.53	0.72	0.47	0.09	-0.29
Free Cash Flow Per Share TTM	4.36	3.97	3.39	3.52	3.46	3.19	3.80	3.45	2.96	3.47	2.74	3.03
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	2.90%	3.04%	2.98%	3.42%	3.70%	5.72%	5.89%	6.64%	6.24%	6.11%	6.07%	3.90%
Net Profit Margin TTM	-0.25%	-0.91%	-0.65%	-0.76%	-2.17%	0.15%	1.52%	2.26%	3.02%	1.88%	0.38%	-1.14%
Growth Metrics
Net Revenue Growth (1Y)	14.72%	11.51%	11.09%	11.33%	12.76%	13.18%	12.20%	12.14%	12.10%	13.05%	14.56%	12.20%
Net Income Growth (1Y)	-86.54%	-767.81%	-147.99%	-137.56%	-181.04%	-90.79%	352.34%	-321.55%	-517.06%	184.85%	-39.37%	-157.67%
EPS Growth (1Y)	-87.01%	-748.69%	-146.44%	-137.09%	-175.51%	-91.99%	317.25%	-280.70%	-447.22%	152.21%	-49.25%	-153.99%
Valuation Metrics
P/E TTM	-789.07	-287.63	-448.90	-291.28	-91.22	1,826.32	189.80	111.84	67.41	72.87	321.73	-111.89
P/B TTM	3.18	3.96	4.41	4.54	3.25	4.50	4.55	3.96	3.13	2.72	2.40	3.29
P/S TTM	2.01	2.63	2.94	2.22	1.98	2.79	2.88	2.52	2.03	1.37	1.21	1.28
Market Cap	4.31B	5.36B	5.79B	4.23B	3.70B	5.10B	5.10B	4.33B	3.37B	2.21B	1.91B	1.95B
Enterprise Value	4.94B	5.70B	6.08B	4.54B	3.99B	5.38B	5.37B	4.61B	3.68B	2.70B	2.43B	2.46B
Calculated Values
Free Cash Flow TTM	336.31M	298.82M	257.19M	261.76M	257.42M	233.02M	279.41M	253.26M	205.34M	220.86M	185.59M	181.36M
Net Debt	631.14M	334.10M	291.62M	306.37M	292.81M	276.25M	270.73M	284.93M	307.66M	487.47M	522.46M	507.67M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-18Sale

Owner: Swartz, David L

Title: -

Shares: 2,699

Price/Share: $53.89

Value: $145,449.11

Shares Owned: 177,013

Relationship: Director

Ownership: Direct

2026-06-16Sale

Owner: Wesdorp, Cornelis

Title: Pres & CEO, Digital Health

Shares: 4,750

Price/Share: $58.11

Value: $276,022.50

Shares Owned: 69,075

Relationship: Officer

Ownership: Direct

2026-06-15Sale

Owner: Forthuber, Stephen M

Title: Pres & CEO-Eastern Operations

Shares: 44,067

Price/Share: $58.20

Value: $2,564,699.40

Shares Owned: 507,199

Relationship: Officer

Ownership: Direct

2026-03-19Sale

Owner: Sorensen, Alma Gregory

Title: Chief Strategy Officer

Shares: 15,000

Price/Share: $62.75

Value: $941,250.00

Shares Owned: 1,208,923

Relationship: Director,Officer

Ownership: Direct

2026-03-18Sale

Owner: Sorensen, Alma Gregory

Title: Chief Strategy Officer

Shares: 15,000

Price/Share: $62.42

Value: $936,300.00

Shares Owned: 1,223,923

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-18	Swartz, David L	Director	-	Direct	Sale	2,699	53.89	$145,449.11	177,013	4
2026-06-16	Wesdorp, Cornelis	Officer	Pres & CEO, Digital Health	Direct	Sale	4,750	58.11	$276,022.50	69,075	4
2026-06-15	Forthuber, Stephen M	Officer	Pres & CEO-Eastern Operations	Direct	Sale	44,067	58.20	$2,564,699.40	507,199	4
2026-03-19	Sorensen, Alma Gregory	Director,Officer	Chief Strategy Officer	Direct	Sale	15,000	62.75	$941,250.00	1,208,923	4
2026-03-18	Sorensen, Alma Gregory	Director,Officer	Chief Strategy Officer	Direct	Sale	15,000	62.42	$936,300.00	1,223,923	4
2025-12-05	Forthuber, Stephen M	Officer	Pres & COO-Eastern Operations	Direct	Sale	45,088	78.94	$3,559,246.72	529,221	4
2025-11-19	Patel, Mital	Officer	EVP of Fin Planning, CAO	Direct	Sale	15,080	80.05	$1,207,154.00	180,138	4
2025-09-16	Stolper, Mark	Officer	EVP, Chief Financial Officer	Direct	Sale	35,000	73.89	$2,586,150.00	68,012	4
2025-09-16	Katz, David Jeffrey	Officer	EVP and Chief Legal Officer	Direct	Sale	14,000	74.44	$1,042,160.00	68,181	4
2025-09-11	Wesdorp, Cornelis	Officer	Pres & CEO, Digital Health	Direct	Sale	500	72.13	$36,065.00	53,495	4
2025-09-10	Hames, Norman R	Officer	Pres and COO-West Operations	Direct	Sale	10,000	72.74	$727,400.00	239,183	4
2025-09-09	Wesdorp, Cornelis	Officer	Pres & CEO, Digital Health	Direct	Sale	500	71.99	$35,995.00	53,995	4
2025-08-27	Hames, Norman R	Officer	Pres and COO-West Operations	Indirect	Sale	5,000	71.10	$355,500.00	19,889	4
2025-08-19	Jayanathan, Ranjan	Officer	Chief Information Officer	Direct	Sale	65,598	67.50	$4,427,865.00	138,198	4
2025-08-19	Wesdorp, Cornelis	Officer	Pres & CEO, Digital Health	Direct	Sale	1,500	66.98	$100,470.00	54,495	4
2025-08-13	Katz, David Jeffrey	Officer	EVP and Chief Legal Officer	Direct	Sale	17,000	68.31	$1,161,270.00	86,774	4
2025-06-05	Murdock, Michael N	Officer	EVP, Mergers and Acquisitions	Direct	Sale	11,132	58.05	$646,212.60	43,084	4
2025-05-23	Sorensen, Alma Gregory	Director,Officer	EVP, Chief Science Officer	Direct	Sale	55,000	56.48	$3,106,400.00	1,160,509	4
2025-05-16	Forthuber, Stephen M	Officer	Pres & COO-Eastern Operations	Direct	Sale	18,820	60.34	$1,135,598.80	535,182	4
2025-05-16	Levitt, Lawrence L	Director	-	Direct	Sale	5,000	61.09	$305,450.00	164,957	4
2025-05-15	Hames, Norman R	Officer	Pres and COO-West Operations	Direct	Sale	5,536	60.00	$332,160.00	249,183	4
2025-03-19	Hames, Norman R	Officer	Pres and COO-West Operations	Direct	Sale	5,000	50.22	$251,100.00	251,959	4
2025-03-07	Wesdorp, Cornelis	Officer	Pres & CEO, Digital Health	Direct	Sale	1,000	50.52	$50,520.00	55,995	4
2025-03-07	Swartz, David L	Director	-	Direct	Sale	25,000	50.84	$1,271,000.00	174,067	4
2024-11-25	Katz, David Jeffrey	Officer	EVP and Chief Legal Officer	Direct	Sale	12,300	81.72	$1,005,156.00	62,909	4
2024-11-19	Jayanathan, Ranjan	Officer	Chief Information Officer	Direct	Sale	38,557	80.00	$3,084,560.00	192,724	4
2024-08-21	Murdock, Michael N	Officer	EVP, Mergers and Acquisitions	Direct	Sale	15,000	62.82	$942,300.00	48,144	4
2024-06-18	Patel, Mital	Officer	EVP, Chief Admin Officer	Direct	Sale	29,800	59.00	$1,758,200.00	202,146	4
2024-06-18	Spurlock, Gregory E.	Director	-	Direct	Sale	7,167	59.75	$428,228.25	2,591	4
2024-06-14	Levitt, Lawrence L	Director	-	Direct	Sale	4,000	57.77	$231,080.00	172,657	4
2024-06-12	Forthuber, Stephen M	Officer	Pres & COO-Eastern Operations	Direct	Sale	40,000	62.33	$2,493,200.00	523,561	4
2024-06-12	Sorensen, Alma Gregory	Director,Officer	EVP, Chief Science Officer	Direct	Sale	10,000	62.34	$623,400.00	1,239,205	4
2024-06-12	Murdock, Michael N	Officer	EVP, Mergers and Acquisitions	Direct	Sale	10,000	62.51	$625,100.00	63,144	4
2024-06-12	Hames, Norman R	Officer	Pres and COO-West Operations	Direct	Sale	18,597	63.08	$1,173,098.76	227,322	4
2024-06-12	Swartz, David L	Director	-	Direct	Sale	4,066	62.42	$253,799.72	196,476	4
2024-06-10	Levitt, Lawrence L	Director	-	Direct	Sale	16,000	60.85	$973,600.00	174,066	4
2024-06-10	Gordon, Christine Nayoma	Director	-	Direct	Sale	1,500	61.03	$91,545.00	10,879	4
2024-06-10	Stolper, Mark	Officer	EVP, Chief Financial Officer	Direct	Sale	25,000	61.27	$1,531,750.00	80,398	4
2024-06-07	Katz, David Jeffrey	Officer	EVP and Chief Legal Officer	Direct	Sale	16,400	61.26	$1,004,664.00	65,441	4
2023-12-05	Murdock, Michael N	Officer	EVP & Chief Development Offcr	Direct	Sale	10,115	35.02	$354,227.30	68,432	4
2023-11-27	Gordon, Christine Nayoma	Director	-	Direct	Sale	3,000	32.40	$97,200.00	10,385	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

90.45%

Inst. Shares: 69,701,425

Shares Outstanding: 77,057,835

2025-12-31

93.50%

Inst. Shares: 70,303,907

Shares Outstanding: 75,189,872

2025-09-30

90.09%

Inst. Shares: 68,420,576

Shares Outstanding: 75,950,350

2025-06-30

89.07%

Inst. Shares: 66,229,017

Shares Outstanding: 74,352,498

2025-03-31

85.74%

Inst. Shares: 63,773,327

Shares Outstanding: 74,382,356

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	69,701,425	77,057,835	90.45%
2025-12-31	70,303,907	75,189,872	93.50%
2025-09-30	68,420,576	75,950,350	90.09%
2025-06-30	66,229,017	74,352,498	89.07%
2025-03-31	63,773,327	74,382,356	85.74%
2024-12-31	59,940,075	73,037,237	82.07%
2024-09-30	59,037,414	73,494,709	80.33%
2024-06-30	57,801,711	73,419,124	78.73%
2024-03-31	57,082,865	69,307,078	82.36%
2023-12-31	50,214,648	63,580,059	78.98%
2023-09-30	50,129,402	67,793,404	73.94%
2023-06-30	49,329,702	59,880,803	82.38%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

RadNet, Inc. (RDNT) — SEC Financial Statements & Analysis

RadNet, Inc. (RDNT) is a services-medical laboratories company, incorporated in DE. RadNet, Inc. trades on RDNT: Nasdaq as: RDNT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), RadNet, Inc. reported a 14.72% year-over-year revenue growth, a Debt-to-Equity ratio of 1.87x, a Price-to-Sales (P/S) ratio of 2.01x (TTM), a Price-to-Book (P/B) ratio of 3.18 (TTM), at a market cap of $4.31B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 14.72%
Debt To Equity: 1.87x
P/S TTM: 2.01x
P/B TTM: 3.18
Market Cap: $4.31B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RadNet, Inc. in?

RadNet, Inc. (RDNT) operates in the Services-Medical Laboratories industry.

What is RDNT's market cap?

RadNet, Inc. (RDNT) has a market capitalization of $4.31B as of 2026-03-31.

What exchange does RDNT trade on?

RadNet, Inc. (RDNT) trades on the RDNT: Nasdaq.

Where is RadNet, Inc. incorporated?

RadNet, Inc. is incorporated in DE.

RadNet, Inc. (RDNT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.